Literature DB >> 21865642

A uroguanylin-GUCY2C endocrine axis regulates feeding in mice.

Michael A Valentino1, Jieru E Lin, Adam E Snook, Peng Li, Gilbert W Kim, Glen Marszalowicz, Michael S Magee, Terry Hyslop, Stephanie Schulz, Scott A Waldman.   

Abstract

Intestinal enteroendocrine cells are critical to central regulation of caloric consumption, since they activate hypothalamic circuits that decrease appetite and thereby restrict meal size by secreting hormones in response to nutrients in the gut. Although guanylyl cyclase and downstream cGMP are essential regulators of centrally regulated feeding behavior in invertebrates, the role of this primordial signaling mechanism in mammalian appetite regulation has eluded definition. In intestinal epithelial cells, guanylyl cyclase 2C (GUCY2C) is a transmembrane receptor that makes cGMP in response to the paracrine hormones guanylin and uroguanylin, which regulate epithelial cell dynamics along the crypt-villus axis. Here, we show that silencing of GUCY2C in mice disrupts satiation, resulting in hyperphagia and subsequent obesity and metabolic syndrome. This defined an appetite-regulating uroguanylin-GUCY2C endocrine axis, which we confirmed by showing that nutrient intake induces intestinal prouroguanylin secretion into the circulation. The prohormone signal is selectively decoded in the hypothalamus by proteolytic liberation of uroguanylin, inducing GUCY2C signaling and consequent activation of downstream anorexigenic pathways. Thus, evolutionary diversification of primitive guanylyl cyclase signaling pathways allows GUCY2C to coordinate endocrine regulation of central food acquisition pathways with paracrine control of intestinal homeostasis. Moreover, the uroguanylin-GUCY2C endocrine axis may provide a therapeutic target to control appetite, obesity, and metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865642      PMCID: PMC3223926          DOI: 10.1172/JCI57925

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  56 in total

Review 1.  The gut and energy balance: visceral allies in the obesity wars.

Authors:  Michael K Badman; Jeffrey S Flier
Journal:  Science       Date:  2005-03-25       Impact factor: 47.728

2.  Insulin, cGMP, and TGF-beta signals regulate food intake and quiescence in C. elegans: a model for satiety.

Authors:  Young-jai You; Jeongho Kim; David M Raizen; Leon Avery
Journal:  Cell Metab       Date:  2008-03       Impact factor: 27.287

3.  Natural variation in food acquisition mediated via a Drosophila cGMP-dependent protein kinase.

Authors:  Karla R Kaun; Craig A L Riedl; Munmun Chakaborty-Chatterjee; Amsale T Belay; Scott J Douglas; Allen G Gibbs; Marla B Sokolowski
Journal:  J Exp Biol       Date:  2007-10       Impact factor: 3.312

4.  Uroguanylin knockout mice have increased blood pressure and impaired natriuretic response to enteral NaCl load.

Authors:  John N Lorenz; Michelle Nieman; Jenine Sabo; L Philip Sanford; Jennifer A Hawkins; Noeet Elitsur; Lara R Gawenis; Lane L Clarke; Mitchell B Cohen
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

5.  Peripheral oxyntomodulin reduces food intake and body weight gain in rats.

Authors:  Catherine L Dakin; Caroline J Small; Rachel L Batterham; Nicola M Neary; Mark A Cohen; Michael Patterson; Mohammad A Ghatei; Stephen R Bloom
Journal:  Endocrinology       Date:  2004-03-04       Impact factor: 4.736

6.  Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor.

Authors:  Stephen L Carrithers; Cobern E Ott; Michael J Hill; Brett R Johnson; Weiyan Cai; Jason J Chang; Rajesh G Shah; Congmei Sun; Elizabeth A Mann; Manasses C Fonteles; Leonard R Forte; Brian A Jackson; Ralph A Giannella; Richard N Greenberg
Journal:  Kidney Int       Date:  2004-01       Impact factor: 10.612

7.  Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.

Authors:  Viola Andresen; Michael Camilleri; Irene A Busciglio; April Grudell; Duane Burton; Sanna McKinzie; Amy Foxx-Orenstein; Caroline B Kurtz; Vineeta Sharma; Jeffrey M Johnston; Mark G Currie; Alan R Zinsmeister
Journal:  Gastroenterology       Date:  2007-07-03       Impact factor: 22.682

8.  Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.

Authors:  Laurie L Baggio; Qingling Huang; Theodore J Brown; Daniel J Drucker
Journal:  Gastroenterology       Date:  2004-08       Impact factor: 22.682

9.  The development of obesity in genetically diabetic-obese (db/db) mice pair-fed with lean siblings. The importance of thermoregulatory thermogenesis.

Authors:  P Trayhurn; L Fuller
Journal:  Diabetologia       Date:  1980-08       Impact factor: 10.122

10.  Weight-reducing effects of the plasma protein encoded by the obese gene.

Authors:  J L Halaas; K S Gajiwala; M Maffei; S L Cohen; B T Chait; D Rabinowitz; R L Lallone; S K Burley; J M Friedman
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

View more
  68 in total

1.  Gastrointestinal hormones: uroguanylin-a new gut-derived weapon against obesity?

Authors:  Gema Frühbeck
Journal:  Nat Rev Endocrinol       Date:  2011-11-15       Impact factor: 43.330

Review 2.  The endocrinology of food intake.

Authors:  Denovan P Begg; Stephen C Woods
Journal:  Nat Rev Endocrinol       Date:  2013-07-23       Impact factor: 43.330

3.  Guanylin and uroguanylin stimulate lipolysis in human visceral adipocytes.

Authors:  A Rodríguez; J Gómez-Ambrosi; V Catalán; S Ezquerro; L Méndez-Giménez; S Becerril; P Ibáñez; N Vila; M A Margall; R Moncada; V Valentí; C Silva; J Salvador; G Frühbeck
Journal:  Int J Obes (Lond)       Date:  2016-04-25       Impact factor: 5.095

Review 4.  GUCY2C ligand replacement to prevent colorectal cancer.

Authors:  Erik S Blomain; Amanda M Pattison; Scott A Waldman
Journal:  Cancer Biol Ther       Date:  2016-04-22       Impact factor: 4.742

Review 5.  New advances in models and strategies for developing anti-obesity drugs.

Authors:  Gilbert W Kim; Jieru E Lin; Erik S Blomain; Scott A Waldman
Journal:  Expert Opin Drug Discov       Date:  2013-04-29       Impact factor: 6.098

6.  Silencing the GUCA2A-GUCY2C tumor suppressor axis in CIN, serrated, and MSI colorectal neoplasia.

Authors:  Babar Bashir; Dante J Merlino; Jeffrey A Rappaport; Esteban Gnass; Juan P Palazzo; Ying Feng; Eric R Fearon; Adam E Snook; Scott A Waldman
Journal:  Hum Pathol       Date:  2019-02-02       Impact factor: 3.466

7.  Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8+ T Cells.

Authors:  Bo Xiang; Trevor R Baybutt; Lisa Berman-Booty; Michael S Magee; Scott A Waldman; Vitali Y Alexeev; Adam E Snook
Journal:  J Immunol       Date:  2017-03-24       Impact factor: 5.422

8.  Intestinal Enteroids Model Guanylate Cyclase C-Dependent Secretion Induced by Heat-Stable Enterotoxins.

Authors:  Amanda M Pattison; Erik S Blomain; Dante J Merlino; Fang Wang; Mary Ann S Crissey; Crystal L Kraft; Jeff A Rappaport; Adam E Snook; John P Lynch; Scott A Waldman
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

9.  GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome.

Authors:  Peng Li; Evan Wuthrick; Jeff A Rappaport; Crystal Kraft; Jieru E Lin; Glen Marszalowicz; Adam E Snook; Tingting Zhan; Terry M Hyslop; Scott A Waldman
Journal:  Cancer Res       Date:  2017-09-15       Impact factor: 12.701

10.  Pilot Study Measuring the Novel Satiety Hormone, Pro-Uroguanylin, in Adolescents With and Without Obesity.

Authors:  Matthew D Di Guglielmo; Dalal Tonb; Zhaoping He; Adebowale Adeyemi; Kenneth L van Golen
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-03       Impact factor: 2.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.